Literature DB >> 10997940

Topological alteration of the CYP3A4 active site by the divalent cation Mg(2+).

M L Schrag1, L C Wienkers.   

Abstract

Phenyldiazene reacted with lymphoblast-expressed CYP3A4 to give a stable phenyl-iron complex that could be induced to rearrange in situ producing approximately equal amounts of four N-phenyl-protoporphyrin IX isomers (N(B):N(A):N(C):N(D), 01:01:02:02). In the presence of 10 mM MgCl(2), the formation profile of the protoporphyrin isomers was markedly altered compared with control, favoring the N(A) isomer (N(B):N(A):N(C):N(D), 01:34:01:02). In addition, an investigation of MgCl(2) effects on CYP3A4-mediated metabolism of triazolam revealed that 10 mM MgCl(2) increased the apparent K(m) of triazolam 4-hydroxylation from 83 to 173 microM and reduced the V(max) for the reaction from 3.4 to 2.4 min(-1). Moreover, when the reaction kinetics of the oxidation of pyrene by CYP3A4 was examined in the absence of MgCl(2), it was found that the substrate-velocity curve was best approximated by a sigmoidal velocity curve (Hill coefficient 1.7 +/- 0.1). However, when the reaction was conducted in the presence of 10 mM MgCl(2), the resulting pyrene kinetics was not sigmoidal but rather biphasic (Hill coefficient 0.80 +/- 0.07). Based on the current results, it appears that CYP3A4 is conformationally sensitive to its in vitro environment and parameters, such as the presence of a divalent magnesium, can have a measurable effect on active site topography and consequently catalytic activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997940

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

1.  Enzyme source effects on CYP2C9 kinetics and inhibition.

Authors:  Vikas Kumar; Dan A Rock; Chad J Warren; Timothy S Tracy; Jan L Wahlstrom
Journal:  Drug Metab Dispos       Date:  2006-08-23       Impact factor: 3.922

Review 2.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

3.  Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.

Authors:  Tamara N Tsalkova; Nadezhda Y Davydova; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

4.  Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probe.

Authors:  Dmitri R Davydov; Alexandra E Botchkareva; Nadezhda E Davydova; James R Halpert
Journal:  Biophys J       Date:  2005-04-15       Impact factor: 4.033

5.  Resolution of multiple substrate binding sites in cytochrome P450 3A4: the stoichiometry of the enzyme-substrate complexes probed by FRET and Job's titration.

Authors:  Harshica Fernando; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

6.  Simultaneous measurement of CYP1A2 activity, regioselectivity, and coupling: Implications for environmental sensitivity of enzyme-substrate binding.

Authors:  Matthew J Traylor; Jack Chai; Douglas S Clark
Journal:  Arch Biochem Biophys       Date:  2010-10-08       Impact factor: 4.013

7.  Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity.

Authors:  Namandjé N Bumpus; Paul F Hollenberg
Journal:  Mol Pharmacol       Date:  2008-07-11       Impact factor: 4.436

8.  Allosteric transitions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; James R Halpert
Journal:  Biochemistry       Date:  2008-10-02       Impact factor: 3.162

Review 9.  Cooperative properties of cytochromes P450.

Authors:  Ilia G Denisov; Daniel J Frank; Stephen G Sligar
Journal:  Pharmacol Ther       Date:  2009-06-23       Impact factor: 12.310

Review 10.  Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

Authors:  Shufeng Zhou; Sui Yung Chan; Boon Cher Goh; Eli Chan; Wei Duan; Min Huang; Howard L McLeod
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.